Trial Profile
Immune and Genetic Correlates of Response to Zoster Vaccine in the Frail Elderly: a Pilot Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 May 2022
Price :
$35
*
At a glance
- Drugs Varicella zoster virus vaccine (Primary)
- Indications Varicella zoster virus infections
- Focus Pharmacodynamics; Therapeutic Use
- 05 Oct 2016 Status changed from active, no longer recruiting to completed,according to the results published in the Journal of Infectious Diseases.
- 05 Oct 2016 Results published in the Journal of Infectious Diseases
- 13 Nov 2015 Planned End Date changed from 1 Dec 2014 to 1 Dec 2015 as reported by ClinicalTrials.gov record.